Skip to content

Effectiveness of strong manual acupuncture (SMA) for lumbar disk herniation: a randomised controlled trial

Study on Therapeutic effect of Acupuncture on LDH based on inflammation and autophagy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005872
Enrollment
Unknown
Registered
2022-04-16
Start date
2022-04-05
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disk herniation

Interventions

Sponsors

Guangdong second traditional Chinese Medicine Hospital, Guangzhou City, Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria of LDH secondary neuralgia, (2) age 18-60 years old; course of disease 1-6 months; (3) do not receive relevant treatment one week before the start of the study; (4) voluntarily participate in the study and sign informed consent; (5) agree to abide by the research program and complete the study strictly in accordance with the requirements in the program.

Exclusion criteria

Exclusion criteria: (1) those who were completely ineffective after conservative treatment for 6 months before entering the group; (2) surgical treatment of lumbar intervertebral disc within 6 months; (3) imaging examination showed that there were severe deformities, tuberculosis and tumors in the lumbar spine; (4) patients with serious medical diseases, such as diabetes, people with disturbance of consciousness; (5) abnormal skin sensation, skin ulcers at acupoints, bleeding, etc., which are not suitable for acupuncture treatment. (6) suspected sedative hypnotics, opioid analgesics, alcohol abuse and drug allergy; long-term use of anticoagulants such as warfarin and aspirin, or abnormal blood coagulation; (7) pregnant or lactating women; (8) those who have received acupuncture treatment or are participating in other clinical trials in the past week; (9) those whose examination data are incomplete or unable to cooperate with the treatment.

Design outcomes

Primary

MeasureTime frame
NRS;ODI;Quality of life;

Countries

China

Contacts

Public ContactFan dehui
1317073040@qq.com13246435796

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026